Decades ago, smoking culture was negatively perceived, with marijuana smoking being frowned upon, leading to restrictive laws. However, the recent widespread legalization of marijuana has shifted perspectives, offering new opportunities
Karina Hernandez’s perfect workplace involves being surrounded by plants, with her hands immersed in the soil. Despite already holding a biology degree, she made the recent choice to return to
Despite announcing a year-end after-tax profit of A$13.8 million, over twice the amount from the previous year, Vitura Health experienced a 10% decrease in its share price yesterday. The company’s
Adam Benjamin, the founder, and CEO of Standard Botanic, engages in a discussion with Cannabiz co-founder Martin Lane and chief correspondent Steve Jones on the following topics: The potential opportunities
One driving force behind the legalization of Cannabis is the potential economic advantages stemming from the regulated commercial availability of marijuana. The prospects of increased tax revenues, job creation, and
The inquiry aims to assess whether the current regulatory and licensing framework for hemp cultivation and products should be simplified to facilitate industry growth. Furthermore, it may explore the feasibility
Cantourage UK, a prominent medical cannabis enterprise in Europe, disclosed the debut of the first-ever medical cannabis flower from New Zealand in partnership with the renowned brand CannFX. About the
Cann Group’s losses more than doubled during the first half of the 2023 financial year due to significant increases in administrative, corporate, and research and development expenses. About the Author
Australian cannabis company, Creso Pharma’s stocks have fallen due to its corporate advisory firm, Sydney-based EverBlu being under an ASIC investigation.
AusCann Group Holdings Limited, an Australian cannabis company has started designing a clinical trial in which will test cannabis medicinal products on those with spinal injuries.
Israeli cannabis start up names Stickit has partnered with one of the leaders in the production of hemp cigarettes, Hempacco, to produce ‘cannabis sticks’.
Australian cannabis company AusCann (ASX: AC8) has announced today of an upcoming trial of cannabinoid treatments to help with spinal cord injuries.
Little Green Pharma, an Australian Cannabis company based in Perth, WA has released its quarterly revenue report. The report shows a record sales month during the month of September.
Cresco Pharma (ASX: CPH) is to set up a deal with a medicinal cannabis company in Switzerland, named Innuana AG, to expand into the medical market.
The share price for Little Green Pharma Ltd (ASX: LGP), an Australian based cannabis company, has risen by 7% in revenue growth, as demand for medicinal cannabis products increases.
Stocks in the cannabis market have been up…then down…then up again. When is the best time to invest in a cannabis stock share, or is the industry still in the decline?
The Green Organic Dutchman, whose headquarters are situated in Ontario, Canada, have just shipped over the first shipment of cannabis for the Australian medical cannabis market.
In this article we look at an interview with Joe Bayern, who is the CEO of Curaleaf Holdings. Curaleaf is one of the biggest cannabis companies in the US based on revenue. Here he talks about the future of the company.
FreshLeaf Analytics, an industry consultancy says that cannabis could soon be on the mainstream market as more doctors and business are changing their attitudes towards CBD and medical cannabis.
ECS Botanics, a medical cannabis company in Australia has recorded its best ever quarter, generating around $900,000 last quarter, giving a 123% increase from the previous quarter.
Blac Sneaker Company in Australia, established in 2019 is doing their bit for climate change by making a donation from every sneaker sale, to help with the planning of new trees.
A large proposed medical cannabis project over a 108-hectare site near Tamworth in New South Wales is now in the public comment phase.
After announcing earlier in the year they were getting rid of their cannabis-screening for new job applicants, Amazon is now calling for cannabis legalisation across the US, as it “disproportionately impacts people of colour”.
Almost 50 kilograms of cannabis flower have now been shipped to Australia from cannabis company Little Green Pharma’s (LGP) facility in Denmark. Two more shipments are expected by the end of October.
Sydney-based cannabis company Cannim has exported cannabis from Jamacia to Germany. The company has invested in farms in both Australia and Jamaica and has now just completed its first legal export.
A new medical cannabis facility, as well as three dispensaries are set to open in Noosa, QLD. These new facilities will provide medicinal help to those from Brisbane and along the Sunshine coast.
As perceptions of cannabis and the decriminalisation of the drug are slowly emerging across the world, a rise in the share market continues. Here we look at the top performers.
Australian cannabis company PharmaCann Global Pty Ltd is jumping on the edible cannabis market with new edible products such as cannabis gummy bears and CBD oils.
Australian cannabis company Little Green Pharma (LGP) has received another large order for this year, to export medicinal cannabis products to Europe. The demand for cannabis exportation is growing rapidly.
Bod Australia is set to release a new cannabigerol (CBG) product, which will be sold under the MediCabilis brand. This will be distributed to various medical facilities within the UK.